30
Participants
Start Date
July 2, 2021
Primary Completion Date
March 1, 2026
Study Completion Date
June 1, 2026
Neoadjuvant Therapy
"Drug:~Camrelizumab 200mg,d1,Repeat every 21 days for 3 courses; Oxaliplatin 130mg/m² ,d1;S-1 40-60mg,Bid, d1-14; S-1: bsa\<1.25m2,40mg/time,twice a day;bsa1.25\~1.5m2,50mg/time,twice a day;bsa≥1.5m2,60mg/次,twice a day,d1-d14;~Procedure: Gastric cancer resection Distal gastrectomy combined with D2 lymph node dissection"
RECRUITING
the First Hospital of Jilin University, Changchun
The First Hospital of Jilin University
OTHER